T
TriSalus Life Sciences Inc
NASDAQ:TLSI
TriSalus Life Sciences Inc
NASDAQ:TLSI
Price:
4.89
USD
-2.2%
Market Closed
Market Cap:
$244.3m
Income Statement
Earnings Waterfall
TriSalus Life Sciences Inc
TriSalus Life Sciences Inc
Income Statement
TriSalus Life Sciences Inc
TriSalus Life Sciences Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
5
|
5
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
N/A
|
10
+113%
|
19
+89%
|
22
+19%
|
31
+42%
|
33
+7%
|
29
-12%
|
39
+31%
|
36
-7%
|
40
+12%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
8
+120%
|
16
+88%
|
19
+20%
|
27
+42%
|
29
+6%
|
25
-12%
|
33
+30%
|
30
-8%
|
34
+11%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(18)
|
(41)
|
(70)
|
(75)
|
(75)
|
(67)
|
(61)
|
(60)
|
(61)
|
(65)
|
|
| Selling, General & Administrative |
(3)
|
0
|
(2)
|
(2)
|
(3)
|
(3)
|
(11)
|
(24)
|
(41)
|
(45)
|
(47)
|
(44)
|
(44)
|
(44)
|
(47)
|
(50)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(16)
|
(30)
|
(30)
|
(33)
|
(28)
|
(18)
|
(21)
|
(14)
|
(15)
|
|
| Other Operating Expenses |
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
6
|
0
|
6
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(3)
-12%
|
(3)
+14%
|
(3)
+13%
|
(3)
-9%
|
(3)
-6%
|
(14)
-382%
|
(32)
-128%
|
(54)
-70%
|
(56)
-2%
|
(52)
+6%
|
(43)
+19%
|
(36)
+15%
|
(32)
+12%
|
(31)
+3%
|
(31)
-1%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
1
|
3
|
3
|
(1)
|
(2)
|
(4)
|
(3)
|
(0)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
|
| Total Other Income |
8
|
11
|
13
|
10
|
6
|
3
|
1
|
18
|
(1)
|
(5)
|
(1)
|
(11)
|
9
|
9
|
4
|
(4)
|
|
| Pre-Tax Income |
5
N/A
|
8
+67%
|
10
+25%
|
9
-10%
|
6
-32%
|
3
-53%
|
(14)
N/A
|
(16)
-16%
|
(59)
-279%
|
(64)
-8%
|
(54)
+15%
|
(55)
-2%
|
(30)
+46%
|
(27)
+9%
|
(31)
-15%
|
(40)
-27%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
5
|
8
|
10
|
9
|
6
|
2
|
(14)
|
(16)
|
(59)
|
(64)
|
(54)
|
(55)
|
(30)
|
(27)
|
(31)
|
(40)
|
|
| Net Income (Common) |
5
N/A
|
8
+67%
|
10
+25%
|
9
-12%
|
6
-37%
|
2
-59%
|
(16)
N/A
|
(19)
-15%
|
(64)
-243%
|
(68)
-7%
|
(57)
+16%
|
(59)
-3%
|
(33)
+43%
|
(30)
+9%
|
(34)
-13%
|
(72)
-111%
|
|
| EPS (Diluted) |
0.15
N/A
|
0.25
+67%
|
0.32
+28%
|
0.28
-12%
|
0.19
-32%
|
0.27
+42%
|
-0.61
N/A
|
-0.7
-15%
|
-6.77
-867%
|
-2.91
+57%
|
-2.38
+18%
|
-2.17
+9%
|
-1.31
+40%
|
-1.06
+19%
|
-1.03
+3%
|
-1.67
-62%
|
|
Switch to:
Switch to:
See Also
Discover More
